Self-Testing and Self Injectable Devices Market: By Product; By Devices; By Application & By Region - Forecast 2016-2022

  • ID: 4033564
  • Report
  • 149 pages
  • IndustryARC
1 of 3
Globally, development of efficient and advanced technologies such as the inclusion of micro needles, rise in the awareness among people, increasing government initiatives across the globe, and growing preference of patients as well as physicians toward pain-free drug delivery are the prime growth drivers of the self-testing and self-injectable devices market. In addition, increase in adoption of self-testing and self-injectable devices for peripheral artery diseases, and emerging economies such as China, India and others, will create new opportunities for the self-testing and self injectable devices market. However, higher cost of research and development, and higher cost of interventional devices are the key restraints for the self-testing and self injectable devices market.

Geographically, North America dominated the global self-testing and self injectable devices market, with approximately half of the world’s consumption being done in the U.S. because of higher healthcare expenditure, medical reimbursement facilities, advanced technologies, and huge investments undertaken by prominent as well as new market entrants. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the products, Blood Glucose Monitoring (BGM) has the fastest growing rate in the self-testing and self injectable devices market due to higher prevalence of diabetic patients.

This report identifies the self-testing and self injectable devices market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the self-testing and self injectable devices market.

This report segments the self-testing and self injectable devices market on the basis of product, devices, application, and regional market as follows:
Self-Testing and Self Injectable Devices Market, By Product: Auto Injectors, Blood Glucose Monitoring (BGM), Double Blood Pump Module (DBPM), Insulin Pump, Activity Monitors, Thermometers, Weighing Machines, and Others
Self-Testing and Self Injectable Devices Market, By Devices: Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free, and Auto Injectors
The report has focused study on self-testing and self injectable devices market by basis of application such as: Diabetes, Oncology, Chronic Diseases, Personal Care, and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the self-testing and self injectable devices market. Some of the major companies’ profiles in detail are as follows:
Becton Dickinson & Co.
Baxter International, Inc.

Bayer Crop Science Ltd.

SHL Group
Ypsomed Holding AG
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Self-Testing and Self Injectable Devices Market – Overview

2. Executive Summary

3. Self-Testing and Self Injectable Devices Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Self-Testing and Self Injectable Devices Market– Forces
4.1. Drivers
4.1.1. Development of efficient and advance technologies such as the inclusion of microneedles
4.1.2. Growing preference of patients as well as physicians toward pain-free drug delivery
4.2. Restraints
4.2.1. Higher cost of research and development
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Self-Testing and Self Injectable Devices Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Self-Testing and Self Injectable Devices Market, By Product
6.1. Auto Injectors
6.2. Blood Glucose Monitoring (BGM)
6.3. Double Blood Pump Module (DBPM)
6.4. Insulin Pump
6.5. Activity Monitors
6.6. Thermometers
6.7. Weighing Machines
6.8. Others

7. Self-Testing and Self Injectable Devices Market, By Devices
7.1. Disposables & Reusable
7.2. Fillable & Prefilled
7.3. Pen
7.4. Needle Free
7.5. Auto Injectors

8. Self-Testing and Self Injectable Devices Market, By Application
8.1. Diabetes
8.2. Oncology
8.3. Chronic Diseases
8.4. Personal Care
8.5. Others

9. Self-Testing and Self Injectable Devices Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW

10. Self-Testing and Self Injectable Devices – Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Becton Dickinson & Co.
11.2. Baxter International, Inc.
11.3. Bayer Crop Science Ltd.
11.4. SHL Group
11.5. Ypsomed Holding AG
11.6. Owen Mumford, Ltd.
11.7. 3M Pharmaceuticals Inc.
11.8. Johnson & Johnson Limited
11.9. GlaxoSmithKline plc
11.10. Novartis AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll